<DOC>
	<DOCNO>NCT02080936</DOCNO>
	<brief_summary>Peripheral muscle mass strength relevant indicator COPD survival . Current guideline recommend assess muscle strength muscle waste patient . However , recent study report quadriceps weakness without muscle wasting ( Menon , M et al . Resp . Res.2012 , 13:119 ) . Thus , guideline raise risk miss weak patient . In clinical setting , fat-free-mass index ( FFMI ) indicate simple index assess muscle waste . We aim determine prevalence patient enter pulmonary rehabilitation ( PR ) priori eligible muscle strength evaluation give lack muscle waste clinical sign .</brief_summary>
	<brief_title>Does Muscle Wasting Always Mean Muscle Weakness ? A Prevalence Study COPD</brief_title>
	<detailed_description />
	<mesh_term>Muscle Weakness</mesh_term>
	<mesh_term>Paresis</mesh_term>
	<mesh_term>Muscular Atrophy</mesh_term>
	<criteria>Patients get FFMI ( bioimpedance ) Patients do quadriceps muscle strenght evaluation Patients without FFMI Patients without quadriceps muscle strenght</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Experimental approach</keyword>
	<keyword>Peripheral muscle Keyword</keyword>
	<keyword>Rehabilitation</keyword>
</DOC>